Premium
Hetero Healthcare Ltd, which is a part of one of the major pharmaceutical groups in India Hetero group, witnessed a modest growth in revenue for the year ended March 2024 after a post-pandemic drop, as it pivots further towards manufacutring. Profitability, however, remained under pressure. Now, the company is expected to post ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
